NasdaqGS:RXRXBiotechs
A Look At Recursion Pharmaceuticals (RXRX) Valuation As Investor Narratives Diverge On Future Potential
Stock performance snapshot
Recursion Pharmaceuticals (RXRX) has drawn investor attention after recent trading left the shares around US$3.28, with mixed performance over the past week, month and past 3 months.
The stock shows a 0.8% decline over 1 day, a 5.6% gain over 7 days, a 4.8% decline over the past month and a 29.5% decline over the past 3 months, alongside a 21.8% decline year to date.
See our latest analysis for Recursion Pharmaceuticals.
Despite the recent 7 day share price return...